The global cancer biopsy market size and share was valued at USD 26.55 billion in 2023 and is expected to grow at a CAGR of 14.8% during the forecast period. This robust growth underscores the escalating need for diagnostic tissue sampling, image-guided biopsy technologies, minimally invasive procedures and consumables across oncology workflows. The market is being propelled by rising cancer...